Skip to main content
GutCited

Berberine Şekiller

35 hakemli araştırmalardan görseller

Tümü Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 11
Figure 11 Chart

Supplementary experimental data (panel 11) from the berberine autoimmune hepatitis study, providing additional evidence of gut microbiota modulation and hepatoprotective effects in the concanavalin A mouse model.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

BBR
Figure 17 Diagram

Graphical summary of berberine's mechanism of action in alleviating concanavalin A-induced autoimmune hepatitis in mice, highlighting its role in modulating the gut microbiota and restoring intestinal barrier integrity.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 18
Figure 18 Chart

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 19
Figure 19 Chart

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 20
Figure 20 Chart

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 29
Figure 29 Chart

Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 30
Figure 30 Chart

Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 35
Figure 35 Chart

Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 40
Figure 40 Chart

Additional supplementary data from the comprehensive berberine autoimmune hepatitis study, further supporting the connection between gut microbiota modulation and liver inflammation resolution.

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut …

Figure 1
Figure 1

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic …

Figure 2. NBCs with potential therapeutic roles in T2D and MASLD.
Figure 3

Figure 2. NBCs with potential therapeutic roles in T2D and MASLD.

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic …

Sayfa 2 / 2